Cargando…
Heparan sulfate is a clearance receptor for aberrant extracellular proteins
The accumulation of aberrant proteins leads to various neurodegenerative disorders. Mammalian cells contain several intracellular protein degradation systems, including autophagy and proteasomal systems, that selectively remove aberrant intracellular proteins. Although mammals contain not only intra...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054991/ https://www.ncbi.nlm.nih.gov/pubmed/32211892 http://dx.doi.org/10.1083/jcb.201911126 |
_version_ | 1783503284492828672 |
---|---|
author | Itakura, Eisuke Chiba, Momoka Murata, Takeshi Matsuura, Akira |
author_facet | Itakura, Eisuke Chiba, Momoka Murata, Takeshi Matsuura, Akira |
author_sort | Itakura, Eisuke |
collection | PubMed |
description | The accumulation of aberrant proteins leads to various neurodegenerative disorders. Mammalian cells contain several intracellular protein degradation systems, including autophagy and proteasomal systems, that selectively remove aberrant intracellular proteins. Although mammals contain not only intracellular but also extracellular proteins, the mechanism underlying the quality control of aberrant extracellular proteins is poorly understood. Here, using a novel quantitative fluorescence assay and genome-wide CRISPR screening, we identified the receptor-mediated degradation pathway by which misfolded extracellular proteins are selectively captured by the extracellular chaperone Clusterin and undergo endocytosis via the cell surface heparan sulfate (HS) receptor. Biochemical analyses revealed that positively charged residues on Clusterin electrostatically interact with negatively charged HS. Furthermore, the Clusterin–HS pathway facilitates the degradation of amyloid β peptide and diverse leaked cytosolic proteins in extracellular space. Our results identify a novel protein quality control system for preserving extracellular proteostasis and highlight its role in preventing diseases associated with aberrant extracellular proteins. |
format | Online Article Text |
id | pubmed-7054991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-70549912020-09-02 Heparan sulfate is a clearance receptor for aberrant extracellular proteins Itakura, Eisuke Chiba, Momoka Murata, Takeshi Matsuura, Akira J Cell Biol Article The accumulation of aberrant proteins leads to various neurodegenerative disorders. Mammalian cells contain several intracellular protein degradation systems, including autophagy and proteasomal systems, that selectively remove aberrant intracellular proteins. Although mammals contain not only intracellular but also extracellular proteins, the mechanism underlying the quality control of aberrant extracellular proteins is poorly understood. Here, using a novel quantitative fluorescence assay and genome-wide CRISPR screening, we identified the receptor-mediated degradation pathway by which misfolded extracellular proteins are selectively captured by the extracellular chaperone Clusterin and undergo endocytosis via the cell surface heparan sulfate (HS) receptor. Biochemical analyses revealed that positively charged residues on Clusterin electrostatically interact with negatively charged HS. Furthermore, the Clusterin–HS pathway facilitates the degradation of amyloid β peptide and diverse leaked cytosolic proteins in extracellular space. Our results identify a novel protein quality control system for preserving extracellular proteostasis and highlight its role in preventing diseases associated with aberrant extracellular proteins. Rockefeller University Press 2020-02-18 /pmc/articles/PMC7054991/ /pubmed/32211892 http://dx.doi.org/10.1083/jcb.201911126 Text en © 2020 Itakura et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Itakura, Eisuke Chiba, Momoka Murata, Takeshi Matsuura, Akira Heparan sulfate is a clearance receptor for aberrant extracellular proteins |
title | Heparan sulfate is a clearance receptor for aberrant extracellular proteins |
title_full | Heparan sulfate is a clearance receptor for aberrant extracellular proteins |
title_fullStr | Heparan sulfate is a clearance receptor for aberrant extracellular proteins |
title_full_unstemmed | Heparan sulfate is a clearance receptor for aberrant extracellular proteins |
title_short | Heparan sulfate is a clearance receptor for aberrant extracellular proteins |
title_sort | heparan sulfate is a clearance receptor for aberrant extracellular proteins |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054991/ https://www.ncbi.nlm.nih.gov/pubmed/32211892 http://dx.doi.org/10.1083/jcb.201911126 |
work_keys_str_mv | AT itakuraeisuke heparansulfateisaclearancereceptorforaberrantextracellularproteins AT chibamomoka heparansulfateisaclearancereceptorforaberrantextracellularproteins AT muratatakeshi heparansulfateisaclearancereceptorforaberrantextracellularproteins AT matsuuraakira heparansulfateisaclearancereceptorforaberrantextracellularproteins |